Tuesday, July 29, 2025
Dividend Dome
  • Politics
  • Business
  • Investing
  • Stock
No Result
View All Result
  • Politics
  • Business
  • Investing
  • Stock
No Result
View All Result
Dividend Dome
No Result
View All Result
Home Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

July 28, 2025
in Investing
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Previous Post

Maiden Drill Program Commences at Oasis Uranium Project

 Next Post

UnitedHealth says it faces DOJ investigation over Medicare billing practices

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent News

    Sranan Gold

    Sranan Gold

    July 29, 2025
    Barrick Backs Hercules in Leviathan-Linked Copper Expansion

    Barrick Backs Hercules in Leviathan-Linked Copper Expansion

    July 29, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 dividenddome.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contact us
    • Home 1
    • Privacy Policy
    • Terms & Conditions
    • Thank you

    Copyright © 2025 dividenddome.com | All Rights Reserved